|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zender L, Villanueva A, Tovar V, Sia D,
Chiang DY and Llovet JM: Cancer gene discovery in hepatocellular
carcinoma. J Hepatol. 52:921–929. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schvartzman JM, Sotillo R and Benezra R:
Mitotic chromosomal instability and cancer: Mouse modelling of the
human disease. Nat Rev Cancer. 10:102–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Westhorpe FG and Straight AF: Functions of
the centromere and kinetochore in chromosome segregation. Curr Opin
Cell Biol. 25:334–340. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pfau SJ and Amon A: Chromosomal
instability and aneuploidy in cancer: From yeast to man. EMBO Rep.
13:515–527. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fukagawa T, Mikami Y, Nishihashi A,
Regnier V, Haraguchi T, Hiraoka Y, Sugata N, Todokoro K, Brown W
and Ikemura T: CENP-H, a constitutive centromere component, is
required for centromere targeting of CENP-C in vertebrate cells.
EMBO J. 20:4603–4617. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tomonaga T, Matsushita K, Ishibashi M,
Nezu M, Shimada H, Ochiai T, Yoda K and Nomura F: Centromere
protein H is up-regulated in primary human colorectal cancer and
its overexpression induces aneuploidy. Cancer Res. 65:4683–4689.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo XZ, Zhang G, Wang JY, Liu WL, Wang F,
Dong JQ, Xu LH, Cao JY, Song LB and Zeng MS: Prognostic relevance
of Centromere protein H expression in esophageal carcinoma. BMC
Cancer. 8:2332008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Quan T, He B, Liu T, Li W, Wu S, Jiang Q,
Liu W, Liu H and Xu X: Role of centromere protein H in human
gastric cancer cell proliferation. Nan Fang Yi Ke Da Xue Xue Bao.
32:265–269. 2012.(In Chinese). PubMed/NCBI
|
|
12
|
He WL, Li YH, Yang DJ, Song W, Chen XL,
Liu FK, Wang Z, Li W, Chen W, Chen CY, et al: Combined evaluation
of centromere protein H and Ki-67 as prognostic biomarker for
patients with gastric carcinoma. Eur J Surg Oncol. 39:141–149.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liao WT, Feng Y, Li ML, Liu GL, Li MZ,
Zeng MS and Song LB: Overexpression of centromere protein H is
significantly associated with breast cancer progression and overall
patient survival. Chin J Cancer. 30:627–637. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weng MY, Li L, Hong SJ and Feng SY:
Clinical significance of CENP-H expression in uterine cervical
cancer. Cancer Biol Med. 9:192–196. 2012.PubMed/NCBI
|
|
15
|
Lu G, Shan T, He S, Ren M, Zhu M, Hu Y, Lu
X and Zhang D: Overexpression of CENP-H as a novel prognostic
biomarker for human hepatocellular carcinoma progression and
patient survival. Oncol Rep. 30:2238–2244. 2013.PubMed/NCBI
|
|
16
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Orthaus S, Ohndorf S and Diekmann S: RNAi
knockdown of human kinetochore protein CENP-H. Biochem Biophys Res
Commun. 348:36–46. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liao WT, Yu CP, Wu DH, Zhang L, Xu LH,
Weng GX, Zeng MS, Song LB and Li JS: Upregulation of CENP-H in
tongue cancer correlates with poor prognosis and progression. J Exp
Clin Cancer Res. 28:742009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luo Y, Ren F, Liu Y, Shi Z, Tan Z, Xiong
H, Dang Y and Chen G: Clinicopathological and prognostic
significance of high Ki-67 labeling index in hepatocellular
carcinoma patients: A meta-analysis. Int J Clin Exp Med.
8:10235–10247. 2015.PubMed/NCBI
|
|
20
|
Athanasoula KC, Gogas H, Polonifi K,
Vaiopoulos AG, Polyzos A and Mantzourani M: Survivin beyond
physiology: Orchestration of multistep carcinogenesis and
therapeutic potentials. Cancer Lett. 347:175–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Andersen MH, Svane IM, Becker JC and
Straten PT: The universal character of the tumor-associated antigen
survivin. Clin Cancer Res. 13:5991–5994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang JX, Zhang YY, Yu XM, Jin T and Pan
XL: Role of centromere protein H and Ki67 in relapse-free survival
of patients after primary surgery for hypopharyngeal cancer. Asian
Pac J Cancer Prev. 13:821–825. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lakhani SA, Masud A, Kuida K, Porter GA
Jr, Booth CJ, Mehal WZ, Inayat I and Flavell RA: Caspases 3 and 7:
Key mediators of mitochondrial events of apoptosis. Science.
311:847–851. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Zhu Z, Zhang S, Yu D, Yu H, Liu L,
Cao X, Wang L, Gao H and Zhu M: ShRNA-targeted centromere protein A
inhibits hepatocellular carcinoma growth. PLoS One. 6:e177942011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lindsay J, Esposti MD and Gilmore AP:
Bcl-2 proteins and mitochondria - specificity in membrane targeting
for death. Biochim Biophys Acta. 1813:532–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Autret A and Martin SJ: Emerging role for
members of the Bcl-2 family in mitochondrial morphogenesis. Mol
Cell. 36:355–363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Howells CC, Baumann WT, Samuels DC and
Finkielstein CV: The Bcl-2-associated death promoter (BAD) lowers
the threshold at which the Bcl-2-interacting domain death agonist
(BID) triggers mitochondria disintegration. J Theor Biol.
271:114–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Taylor RC, Cullen SP and Martin SJ:
Apoptosis: Controlled demolition at the cellular level. Nat Rev Mol
Cell Biol. 9:231–241. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brancolini C, Lazarevic D, Rodriguez J and
Schneider C: Dismantling cell-cell contacts during apoptosis is
coupled to a caspase-dependent proteolytic cleavage of
beta-catenin. J Cell Biol. 139:759–771. 1997. View Article : Google Scholar : PubMed/NCBI
|
